Rituximab as an effective therapeutic option in refractory Neuro-Behçet syndrome.

Garcia-Estrada, Christian; Casallas-Vanegas, Adriana; Zabala-Angeles, Indhira; Gomez-Figueroa, Enrique; Rivas-Alonso, Verónica; Flores-Rivera, José.

Afiliação

Garcia-Estrada C; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico. Electronic address: christianalan.cg@gmail.com.
Casallas-Vanegas A; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Zabala-Angeles I; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Gomez-Figueroa E; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Rivas-Alonso V; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
Flores-Rivera J; Multiple sclerosis and Demyelinating disorders Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico; Head of Neurology Department National Institute of Neurology and Neurosurgery, Mexico City, Mexico.

J Neuroimmunol ; 346: 577308, 2020 Jun 26.

Article em En | MEDLINE | ID: mdl-32619893